http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5863781-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f244c6155c2c1d73694b62b1c889927 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 1996-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1157d340d2dd4199ad8e0e13fa4169 |
| publicationDate | 1999-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5863781-A |
| titleOfInvention | Protein tyrosine phosphatase which localizes to focal adhesions |
| abstract | DNA which encodes a protein homologous to the protein tyrosine phosphatases (PTPases) which catalyze the dephosphorylation of proteins in which tyrosyl residues have been phosphorylated through the action of a protein kinase. The protein, which appears as if it will localize to focal adhesions, is also the subject of the present invention. In particular, it relates to cDNA encoding a protein, referred to as PTPH1. n Overexpression of PTPH1 may be a powerful approach to countering the effects of oncogenic protein tyrosine kinases, such as those of transforming viruses, and interfering with or reversing cell transformation. This would provide a means of preventing or reversing abnormally high levels of phosphotyrosine associated with any disease or condition, such as preventing or reversing malignancy associated with the activity of a protein tyrosine kinase. n In the present method, DNA or RNA encoding PTPH1 or a functional equivalent of PTPH1 is administered to an individual in an appropriate gene transfer vehicle which can infect mammalian cells and, once inside the mammalian cells, express and make available PTPH1 or its functional equivalent in sufficient quantities to overcome or counteract the protein tyrosine kinase activity. As a result, phosphorylation of tyrosine residues at abnormal levels is prevented or reversed, resulting in turn in prevention or reversal of malignancy of cells. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248327-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7176289-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006198847-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6479640-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6482024-B1 |
| priorityDate | 1990-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.